Dr. Monica Vetter, MD
Claim this profileBaptist Health Lexington
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
6 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Monica Vetter, MD is currently running
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
ONC-392 + Pembrolizumab
for Ovarian Cancer
This is a study to test the safety and efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian cancer patients.
Recruiting2 awards Phase 212 criteria
More about Monica Vetter, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Monica Vetter, MD has experience with
- Abemaciclib
- Letrozole
- Pembrolizumab
- ONC-392
- Da Vinci
- Open Surgery
Breakdown of trials Monica Vetter, MD has run
Ovarian Cancer
Fallopian Tube Cancer
Serous Cystadenocarcinoma
Endometrial Cancer
Peritoneal Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Monica Vetter, MD specialize in?
Monica Vetter, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved BRCA1 positive patients, or patients who are undergoing treatment.
Is Monica Vetter, MD currently recruiting for clinical trials?
Yes, Monica Vetter, MD is currently recruiting for 5 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Monica Vetter, MD has studied deeply?
Yes, Monica Vetter, MD has studied treatments such as Abemaciclib, Letrozole, Pembrolizumab.
What is the best way to schedule an appointment with Monica Vetter, MD?
Apply for one of the trials that Monica Vetter, MD is conducting.
What is the office address of Monica Vetter, MD?
The office of Monica Vetter, MD is located at: Baptist Health Lexington, Lexington, Kentucky 40503 United States. This is the address for their practice at the Baptist Health Lexington.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.